2024 CHHD Research Day
Welcome to the 9th Annual Child Health and Human Development Research Day -
Friday May 10th, 2024
Child Health and Human Development Research Day is organized to provide the program members and guests with information about the research spearheaded by our researchers, reinforce and initiate collaborations.
All CHHD members from the CTB and CORE are invited to participate in this event!
CHHD Trainees will be put forward as we want this event to be an opportunity for you to showcase your results to your peers, receive feedback on your work and most of all, improve your communication skills which is essential for any future researchers.
This Research Day will also allow everyone to familiarize themselves with research from our CHHD members and an Invited Speaker!
We are looking forward to seeing you at this year's CHHD research day!
Registration
Deadline: Monday, April 22, 2024 at 11:59 pm
All attendees must register.
Every presenter is required to register before submitting an abstract.
Submission - Abstract
Deadline: Monday, April 8, 2024 at 11:59pm
All presenters need to submit an abstract and select whether they prefer a poster or oral presentation.
The committee will inform presenters of the type of presentation they were assigned 8 days after the submission deadline.
This is a competition! We will award prizes for the best performance in each category!
Abstract requirements:
- 300 words
- To be submitted in English only
- Only Poster and Oral Presentations by trainees will be considered for the awards.
Poster and oral presentations
Oral Presentations
- We ask that the presenters prepare an 8-minute PowerPoint presentation.
- Each presentation will be followed by a 2-minute question period.
- We ask that each selected presenter provide their PowerPoint presentation via email to murielle.akpa@muhc.mcgill.ca by May 8, 2024 at 11:59pm.
Poster Presentations
- Presenters will be able to put up their poster on the boards available in the Atrium starting at 8:00am on May 10, 2024.
- Presenters will be required to attend their posters during the poster session to present and answer questions.
- Presenter will be asked to prepare a 5-minute presentation.
- Each presentation will be followed by up to 2 minutes of questions.
Awards
Oral Presentations
Senior Oral Presentation: $250
Junior Oral Presentation: $250
Junior Poster Presentations
First Place: $250
Second Place: $175
Third Place: $100
Senior Poster Presentations
First Place: $250
Second Place: $175
Third Place: $100
Good luck to all presenters!
Please take note that the Research Day Abstract booklet will be available at registration on May 10, 2024.
Keynote Speaker
Beatrice Latal MD MPH
Co-Director, Child Development Center
University Children Hospital Zurich
Dr. Latal leads a large research group and is dedicated to teaching and faculty development. In her research, she investigates the developmental outcome of newborns and children at risk for neurodevelopmental disorders. This includes children born very prematurely, children with hypoxic-ischemic encephalopathy (“perinatal asphyxia”) and children with severe congenital heart disease.
Dr. Latal’s main research goals are to characterize the prevalence and severity of neurodevelopmental impairments in these children, to identify the potential risk factors for impairments and to study the mechanisms involved in the etiology of brain injury. Dr. Latal also examines the application of diagnostic tools such as amplitude integrated EEG, cerebral MRI and neurological examination for their potential usefulness as outcome predictors.
CHHD Principal Investigator
Dr. Janusz Rak, MD PhD
Senior Scientist, CHHD
Research Institute of the McGill University Health Centre
Professor, Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill university
Department of Pediatrics, Division of Hematology, MUHC
Dr. Rak's research focuses on the role of the vasculature and blood in aggressiveness and progression of human cancers, especially in the brain, kidney and hematopoietic system. His laboratory studies how angiogenic and clotting factors influence the malignant disease and how to treat tumors more effectively using agents targeting vascular abnormalities. They described cancer-induced vascular processes that are distinct in adult and children. They also focus on cancer-specific interactions between tumor cells and vascular cells by exchange of unique cellular fragments known as extracellular vesicles or exosomes, some of which contain cancer causing genes and regulatory proteins and can serve as unprecedented sources of diagnostic information in cancer. They believe that interruption of intercellular connections represents a new frontier in therapy of human malignancies.
Location
McConnell Atrium and Cruess Auditorium
1001, Boulevard Décarie Montréal, QC Canada, H4A 3J1Registration period
March 1, 2024 - 00:00 until May 3, 2024 - 23:59
Submission period
March 1, 2024 - 00:00 until April 9, 2024 - 23:59
Contact us
If you have any questions, please contact murielle.akpa@muhc.mcgill.ca .
